274
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Association Between C-Reactive Protein and Albumin Ratios and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease

&
Pages 2289-2303 | Received 23 Mar 2023, Accepted 14 Sep 2023, Published online: 18 Oct 2023

References

  • Huang X, Guan W, Xiang B, Wang W, Xie Y, Zheng J. MUC5B regulates goblet cell differentiation and reduces inflammation in a murine COPD model. Respir Res. 2022;23(1):11. doi:10.1186/s12931-021-01920-8
  • Alqahtani JS, Aquilina J, Bafadhel M, et al. Research priorities for exacerbations of COPD. Lancet Respir Med. 2021;9(8):824–826. doi:10.1016/S2213-2600(21)00227-7
  • Halpin DMG, Criner GJ, Papi A, et al. Global initiative for the diagnosis, management, and prevention of chronic obstructive lung disease. The 2020 GOLD science committee report on COVID-19 and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2021;203(1):24–36. doi:10.1164/rccm.202009-3533SO
  • Gupta N, Agrawal S, Chakrabarti S, Ish P. COPD 2020 guidelines - what is new and why? Adv Respir Med. 2020;88(1):38–40. doi:10.5603/ARM.2020.0080
  • Singh D, Agusti A, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164. doi:10.1183/13993003.00164-2019
  • World Health Organization. Chronic respiratory diseases. Burden of COPD; 2019.
  • Esteban C, Castro-Acosta A, Alvarez-Martínez CJ, Capelastegui A, López-Campos JL, Pozo-Rodriguez F. Predictors of one-year mortality after hospitalization for an exacerbation of COPD. BMC Pulm Med. 2018;18(1):18. doi:10.1186/s12890-018-0574-z
  • Kim Y, Kim YJ, Cho WK. Effect of multiple comorbidities on mortality in chronic obstructive pulmonary disease among Korean population: a nationwide cohort study. BMC Pulm Med. 2021;21(1):56. doi:10.1186/s12890-021-01424-7
  • Hamadi H, Stallings-Smith S, Apatu E, Peterson B, Spaulding A. Smoke-Free Policies and 30-Day Mortality Rates for Chronic Obstructive Pulmonary Disease. Int J Health Policy Manag. 2022;11(9):1695–1702. doi:10.34172/ijhpm.2021.74
  • Lambert AA, Putcha N, Drummond MB, et al. Obesity is associated with increased morbidity in moderate to severe COPD. Chest. 2017;151(1):68–77. doi:10.1016/j.chest.2016.08.1432
  • Robichaux C, Aron J, Wendt CH, et al. Sociodemographic and geographic risk factors for all-cause mortality in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2023;18:1587–1593. doi:10.2147/COPD.S406899
  • Nakanishi M, Minakata Y, Tanaka R, et al. Simple standard equation for daily step count in Japanese patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2019;14:1967–1977. doi:10.2147/COPD.S218705
  • Yin P, Wu J, Wang L, et al. The Burden of COPD in China and Its Provinces: findings From the Global Burden of Disease Study 2019. Front Public Health. 2022;10:859499. doi:10.3389/fpubh.2022.859499
  • Barnes PJ. Cellular and molecular mechanisms of chronic obstructive pulmonary disease. Clin Chest Med. 2014;35(1):71–86. doi:10.1016/j.ccm.2013.10.004
  • Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754. doi:10.3389/fimmu.2018.00754
  • Pandey S, Garg R, Kant S, Gaur P. Vitamin D, C-reactive protein, and oxidative stress markers in chronic obstructive pulmonary disease. Tzu Chi Med J. 2021;33(1):80–86. doi:10.4103/tcmj.tcmj_198_19
  • Leuzzi G, Galeone C, Taverna F, Suatoni P, Morelli D, Pastorino U. C-reactive protein level predicts mortality in COPD: a systematic review and meta-analysis. Eur Respir Rev. 2017;26(143):160070. doi:10.1183/16000617.0070-2016
  • Yu H, Su X, Lei T, et al. Effect of Omega-3 fatty acids on chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials. Int J Chron Obstruct Pulmon Dis. 2021;16:2677–2686. doi:10.2147/COPD.S331154
  • Hausman DB, Fischer JG, Johnson MA. Protein, lipid, and hematological biomarkers in centenarians: definitions, interpretation and relationships with health. Maturitas. 2012;71(3):205–212. doi:10.1016/j.maturitas.2011.12.002
  • Qiu Y, Wang Y, Shen N, et al. Association between red blood cell distribution width-albumin ratio and hospital mortality in chronic obstructive pulmonary disease patients admitted to the intensive care unit: a retrospective study. Int J Chron Obstruct Pulmon Dis. 2022;17:1797–1809. doi:10.2147/COPD.S371765
  • Ishida S, Hashimoto I, Seike T, Abe Y, Nakaya Y, Nakanishi H. Serum albumin levels correlate with inflammation rather than nutrition supply in burns patients: a retrospective study. The Journal of Med Invest. 2014;61(3–4):361–368. doi:10.2152/jmi.61.361
  • Lee CS, Devoe CE, Zhu X, Fishbein JS, Seetharamu N. Pretreatment nutritional status and response to checkpoint inhibitors in lung cancer. Lung Cancer Manag. 2020;9(2):Lmt31. doi:10.2217/lmt-2020-0008
  • Sivgin S, Baldane S, Ozenmis T, et al. The impact of pretransplant hypoalbuminemia on survival in patients with leukemia who underwent allogeneic hematopoietic stem cell transplantation (alloHSCT): a nutritional problem? Transplant Proc. 2013;45(9):3371–3374. doi:10.1016/j.transproceed.2013.02.144
  • Abolhassani AR, Schuler G, Kirchberger MC, Heinzerling L. C-reactive protein as an early marker of immune-related adverse events. J Cancer Res Clin Oncol. 2019;145(10):2625–2631. doi:10.1007/s00432-019-03002-1
  • Hizli O, Cayir S, Coluk Y, Kayabasi S, Yildirim G. The novel indicators of moderate to severe sleep apnea: fibrinogen to albumin ratio vs. CRP to albumin ratio. Eur Arch Otorhinolaryngol. 2021;278(3):851–855. doi:10.1007/s00405-019-05770-5
  • Frey A, Martin D, D’Cruz L, Fokas E, Rödel C, Fleischmann M. C-reactive protein to albumin ratio as prognostic marker in locally advanced non-small cell lung cancer treated with chemoradiotherapy. Biomedicines. 2022;10(3):598. doi:10.3390/biomedicines10030598
  • Martin D, Rödel F, Balermpas P, Winkelmann R, Fokas E, Rödel C. C-reactive protein-to-albumin ratio as prognostic marker for anal squamous cell carcinoma treated with chemoradiotherapy. Front Oncol. 2019;9:1200. doi:10.3389/fonc.2019.01200
  • Baldemir R, Öztürk A, Eraslan Doganay G, Cirik MO, Alagoz A. Evaluation of nutritional status in hospitalized chronic obstructive pulmonary disease patients and can c-reactive protein-to-albumin ratio be used in the nutritional risk assessment in these patients. Cureus. 2022;14(2):e21833. doi:10.7759/cureus.21833
  • Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP
  • Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA. 2010;303(20):2043–2050. doi:10.1001/jama.2010.650
  • Gong R, Liu Y, Luo G, Yin J, Xiao Z, Hu T. Using optimal subset regression to identify factors associated with insulin resistance and construct predictive models in the US adult population. Endoc Connect. 2022;11(7). doi:10.1530/EC-22-0066
  • Kammerlander AA, Mayrhofer T, Ferencik M, et al. Association of metabolic phenotypes with coronary artery disease and cardiovascular events in patients with stable chest pain. Diabetes Care. 2021;44(4):1038–1045. doi:10.2337/dc20-1760
  • Liao S, Zhang J, Shi S, et al. Association of aldehyde exposure with cardiovascular disease. Ecotoxicol Environ Saf. 2020;206:111385. doi:10.1016/j.ecoenv.2020.111385
  • Li F, Sun A, Wu F, Zhang D, Zhao Z. Trends in using of antihypertensive medication among US CKD adults, NHANES 2001–2018. Front Cardiovasc Med. 2023;10:990997. doi:10.3389/fcvm.2023.990997
  • Rahman HH, Niemann D, Munson-McGee SH. Urinary metals, arsenic, and polycyclic aromatic hydrocarbon exposure and risk of chronic bronchitis in the US adult population. Environ Sci Pollut Res Int. 2022;29(48):73480–73491. doi:10.1007/s11356-022-20982-9
  • Llanos JP, Ortega H, Germain G, et al. Health characteristics of patients with asthma, COPD and asthma-COPD overlap in the NHANES database. Int J Chron Obstruct Pulmon Dis. 2018;13:2859–2868. doi:10.2147/COPD.S167379
  • Dereli S, Çerik İB, Kaya A, Bektaş O. Assessment of the relationship between C-reactive protein-to-albumin ratio and the presence and severity of isolated coronary artery ectasia. Angiology. 2020;71(9):840–846. doi:10.1177/0003319720930983
  • Yu Y, Wu W, Dong Y, Li J, Steel HC. C-reactive protein-to-albumin ratio predicts sepsis and prognosis in patients with severe burn injury. Mediators Inflamm. 2021;2021:6621101. doi:10.1155/2021/6621101
  • Lin N, Li J, Ke Q, Wang L, Cao Y, Liu J. Clinical significance of C-reactive protein to albumin ratio in patients with hepatocellular carcinoma: a meta-analysis. Dis Markers. 2020;2020:4867974. doi:10.1155/2020/4867974
  • Tsujino T, Komura K, Hashimoto T, et al. C-reactive protein-albumin ratio as a prognostic factor in renal cell carcinoma - A data from multi-institutional study in Japan. Urol Oncol. 2019;37(11):812.e811–812.e818. doi:10.1016/j.urolonc.2019.04.002
  • Uchimoto T, Komura K, Fujiwara Y, et al. Prognostic impact of C-reactive protein-albumin ratio for the lethality in castration-resistant prostate cancer. Med Oncol. 2019;37(1):9. doi:10.1007/s12032-019-1332-7
  • Xu HJ, Ma Y, Deng F, Ju WB, Sun XY, Wang H. The prognostic value of C-reactive protein/albumin ratio in human malignancies: an updated meta-analysis. Onco Targets Ther. 2017;10:3059–3070. doi:10.2147/OTT.S137002
  • Aksoy F, Uysal D, Ibrişim E. Relationship between c-reactive protein/albumin ratio and new-onset atrial fibrillation after coronary artery bypass grafting. Rev Assoc Med Bras. 2020;66(8):1070–1076. doi:10.1590/1806-9282.66.8.1070
  • He Y, Tang J, Wu B, Yang B, Ou Q, Lin J. Correlation between albumin to fibrinogen ratio, C-reactive protein to albumin ratio and Th17 cells in patients with rheumatoid arthritis. Clinica chimica acta. 2020;500:149–154. doi:10.1016/j.cca.2019.10.009
  • Uzum Y, Turkkan E. Predictivity of CRP, albumin, and CRP to albumin ratio on the development of intensive care requirement, mortality, and disease severity in COVID-19. Cureus. 2023;15(1):e33600. doi:10.7759/cureus.33600
  • Tillett WS, Francis T. Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med. 1930;52(4):561–571. doi:10.1084/jem.52.4.561
  • Liu SF, Wang CC, Chin CH, Chen YC, Lin MC. High value of combined serum C-reactive protein and BODE score for mortality prediction in patients with stable COPD. Arch Bronconeumol. 2011;47(9):427–432. doi:10.1016/j.arbres.2011.04.011
  • Aksu F, Capan N, Aksu K, et al. C-reactive protein levels are raised in stable Chronic obstructive pulmonary disease patients independent of smoking behavior and biomass exposure. J Thorac Dis. 2013;5(4):414–421. doi:10.3978/j.issn.2072-1439.2013.06.27
  • Nazha B, Moussaly E, Zaarour M, Weerasinghe C, Azab B. Hypoalbuminemia in colorectal cancer prognosis: nutritional marker or inflammatory surrogate? World J Gastrointest Surg. 2015;7(12):370–377. doi:10.4240/wjgs.v7.i12.370
  • Hallin R, Gudmundsson G, Suppli Ulrik C, et al. Nutritional status and long-term mortality in hospitalised patients with chronic obstructive pulmonary disease (COPD). Respir Med. 2007;101(9):1954–1960. doi:10.1016/j.rmed.2007.04.009
  • Yamauchi Y, Hasegawa W, Yasunaga H, et al. Paradoxical association between body mass index and in-hospital mortality in elderly patients with chronic obstructive pulmonary disease in Japan. Int J Chron Obstruct Pulmon Dis. 2014;9:1337–1346. doi:10.2147/COPD.S75175
  • Keene SJ, Adab P, de Vries F, et al. The stability of the ADO score among UK COPD patients from the health improvement network. ERJ Open Res. 2020;6(1):00196–2019. doi:10.1183/23120541.00196-2019
  • Daujat-Chavanieu M, Gerbal-Chaloin S. Regulation of CAR and PXR expression in health and disease. Cells. 2020;9(11):2395. doi:10.3390/cells9112395
  • Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet. 2004;364(9435):709–721. doi:10.1016/S0140-6736(04)16900-6
  • Lewis DR, Clegg LX, Johnson NJ. Lung disease mortality in the United States: the national longitudinal mortality study. Int J Tuberc Lung Dis. 2009;13(8):1008–1014.